Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

397 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
IL-6-based mortality prediction model for COVID-19: Validation and update in multicenter and second wave cohorts.
Utrero-Rico A, Ruiz-Hornillos J, González-Cuadrado C, Rita CG, Almoguera B, Minguez P, Herrero-González A, Fernández-Ruiz M, Carretero O, Taracido-Fernández JC, López-Rodriguez R, Corton M, Aguado JM, Villar LM, Ayuso-García C, Paz-Artal E, Laguna-Goya R. Utrero-Rico A, et al. Among authors: carretero o. J Allergy Clin Immunol. 2021 May;147(5):1652-1661.e1. doi: 10.1016/j.jaci.2021.02.021. Epub 2021 Mar 1. J Allergy Clin Immunol. 2021. PMID: 33662370 Free PMC article. Clinical Trial.
Effectiveness of anakinra for tocilizumab-refractory severe COVID-19: A single-centre retrospective comparative study.
de la Calle C, López-Medrano F, Pablos JL, Lora-Tamayo J, Maestro-de la Calle G, Sánchez-Fernández M, Fernández-Ruiz M, Pérez-Jacoiste Asín MA, Caro-Teller JM, García-García R, Catalán M, Martínez-López J, Sevillano Á, Origüen J, Ripoll M, San Juan R, Lalueza A, de Miguel B, Carretero O, Aguilar F, Gómez C, Paz-Artal E, Bueno H, Lumbreras C, Aguado JM. de la Calle C, et al. Among authors: carretero o. Int J Infect Dis. 2021 Apr;105:319-325. doi: 10.1016/j.ijid.2021.02.041. Epub 2021 Feb 13. Int J Infect Dis. 2021. PMID: 33592340 Free PMC article.
Combination therapy with tocilizumab and corticosteroids for aged patients with severe COVID-19 pneumonia: A single-center retrospective study.
López-Medrano F, Pérez-Jacoiste Asín MA, Fernández-Ruiz M, Carretero O, Lalueza A, Maestro de la Calle G, Caro JM, de la Calle C, Catalán M, García-García R, Martínez-López J, Origüen J, Ripoll M, San Juan R, Trujillo H, Sevillano Á, Gutiérrez E, de Miguel B, Aguilar F, Gómez C, Silva JT, García-Ruiz de Morales D, Saro-Buendía M, Marrero-Sánchez Á, Chiara-Graciani G, Bueno H, Paz-Artal E, Lumbreras C, Pablos JL, Aguado JM; H12O Immunomodulation Therapy for COVID-19 Group. López-Medrano F, et al. Among authors: carretero o. Int J Infect Dis. 2021 Apr;105:487-494. doi: 10.1016/j.ijid.2021.02.099. Epub 2021 Feb 26. Int J Infect Dis. 2021. PMID: 33647515 Free PMC article.
Tocilizumab therapy in SARS-CoV-2 pneumonia: A matched retrospective cohort analysis.
Fernández-Ruiz M, López-Medrano F, Carretero O, Parra P, Ruiz-Merlo T, Aguado JM; H12O Immunomodulation Therapy for COVID-19 Group. Fernández-Ruiz M, et al. Among authors: carretero o. Med Clin (Barc). 2022 Jun 24;158(12):608-612. doi: 10.1016/j.medcli.2021.06.014. Epub 2021 Jun 18. Med Clin (Barc). 2022. PMID: 34243954 Free PMC article.
Immunogenicity of Anti-SARS-CoV-2 Vaccines in Common Variable Immunodeficiency.
Arroyo-Sánchez D, Cabrera-Marante O, Laguna-Goya R, Almendro-Vázquez P, Carretero O, Gil-Etayo FJ, Suàrez-Fernández P, Pérez-Romero P, Rodríguez de Frías E, Serrano A, Allende LM, Pleguezuelo D, Paz-Artal E. Arroyo-Sánchez D, et al. Among authors: carretero o. J Clin Immunol. 2022 Feb;42(2):240-252. doi: 10.1007/s10875-021-01174-5. Epub 2021 Nov 17. J Clin Immunol. 2022. PMID: 34787773 Free PMC article.
Analysis of the factors predicting clinical response to tocilizumab therapy in patients with severe COVID-19.
San-Juan R, Fernández-Ruiz M, López-Medrano F, Carretero O, Lalueza A, Maestro de la Calle G, Pérez-Jacoiste Asín MA, Bueno H, Caro-Teller JM, Catalán M, de la Calle C, García-García R, Gómez C, Laguna-Goya R, Lizasoáin M, Martínez-López J, Origüen J, Sevillano Á, Gutiérrez E, de Miguel B, Aguilar F, Parra P, Ripoll M, Ruiz-Merlo T, Trujillo H, Pablos JL, Paz-Artal E, Lumbreras C, Aguado JM; H12O Immunomodulation Therapy for COVID-19 Group, the Spanish Network for Research in Infectious Diseases (REIPI). San-Juan R, et al. Among authors: carretero o. Int J Infect Dis. 2022 Apr;117:56-64. doi: 10.1016/j.ijid.2022.01.040. Epub 2022 Jan 23. Int J Infect Dis. 2022. PMID: 35081417 Free PMC article.
Presence of rare potential pathogenic variants in subjects under 65 years old with very severe or fatal COVID-19.
López-Rodríguez R, Del Pozo-Valero M, Corton M, Minguez P, Ruiz-Hornillos J, Pérez-Tomás ME, Barreda-Sánchez M, Mancebo E, Villaverde C, Núñez-Moreno G, Romero R; STOP_Coronavirus Study Group; Paz-Artal E, Guillén-Navarro E, Almoguera B, Ayuso C. López-Rodríguez R, et al. Sci Rep. 2022 Jun 20;12(1):10369. doi: 10.1038/s41598-022-14035-x. Sci Rep. 2022. PMID: 35725860 Free PMC article.
Age-dependent association of clonal hematopoiesis with COVID-19 mortality in patients over 60 years.
Del Pozo-Valero M, Corton M, López-Rodríguez R, Mahillo-Fernández I, Ruiz-Hornillos J, Minguez P, Villaverde C, Pérez-Tomás ME, Barreda-Sánchez M, Mancebo E; STOP_Coronavirus Study Group; Paz-Artal E, Guillén-Navarro E, Almoguera B, Ayuso C. Del Pozo-Valero M, et al. Geroscience. 2023 Feb;45(1):543-553. doi: 10.1007/s11357-022-00666-5. Epub 2022 Oct 3. Geroscience. 2023. PMID: 36184726 Free PMC article.
Brief Research Report: Virus-Specific Humoral Immunity at Admission Predicts the Development of Respiratory Failure in Unvaccinated SARS-CoV-2 Patients.
Tajuelo A, Carretero O, García-Ríos E, López-Siles M, Cano O, Vázquez M, Más V, Rodríguez-Goncer I, Lalueza A, López-Medrano F, Juan RS, Fernández-Ruiz M, Aguado JM, McConnell MJ, Pérez-Romero P. Tajuelo A, et al. Among authors: carretero o. Front Immunol. 2022 Apr 25;13:878812. doi: 10.3389/fimmu.2022.878812. eCollection 2022. Front Immunol. 2022. PMID: 35547738 Free PMC article.
Tocilizumab therapy in SARS-CoV-2 pneumonia: A matched retrospective cohort analysis.
Fernández-Ruiz M, López-Medrano F, Carretero O, Parra P, Ruiz-Merlo T, Aguado JM; H12O Immunomodulation Therapy for COVID-19 Group. Fernández-Ruiz M, et al. Among authors: carretero o. Med Clin (Engl Ed). 2022 Jun 24;158(12):608-612. doi: 10.1016/j.medcle.2021.06.025. Epub 2022 Jun 22. Med Clin (Engl Ed). 2022. PMID: 35761980 Free PMC article.
397 results